Literature DB >> 30765125

Direct-acting antiviral treatment for hepatitis C.

Jacinta A Holmes1, Stephanie M Rutledge2, Raymond T Chung3.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30765125     DOI： 10.1016/S0140-6736(18)32326-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Regional differences in access to direct-acting antiviral treatments for hepatitis C across Ontario: A cross-sectional study.

Authors:  Natalia Konstantelos; Ahmad Shakeri; Daniel McCormack; Anabel Campos-Meade; Tara Gomes; Michelle Murti; Valérie Pierre-Pierre; Mina Tadrous
Journal:  Can Commun Dis Rep       Date:  2022-04-06

2.  Comparison of public and private payments for direct-acting antivirals (DAAs) across Canada.

Authors:  Ahmad Shakeri; Kaleen N Hayes; Tara Gomes; Mina Tadrous
Journal:  Can Liver J       Date:  2021-11-11

3.  Population-Based Testing for Undiagnosed Hepatitis C: A Systematic Review of Economic Evaluations.

Authors:  Paul G Carty; Christopher G Fawsitt; Paddy Gillespie; Patricia Harrington; Michelle O'Neill; Susan M Smith; Conor Teljeur; Mairin Ryan
Journal:  Appl Health Econ Health Policy       Date:  2021-12-06       Impact factor: 3.686

Review 4.  HCV Replicon Systems: Workhorses of Drug Discovery and Resistance.

Authors:  Shaheen Khan; Shalini Soni; Naga Suresh Veerapu
Journal:  Front Cell Infect Microbiol       Date:  2020-06-30       Impact factor: 5.293

5.  Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19.

Authors:  Pramod Kumar; Anand Kulkarni; Mithun Sharma; Padaki N Rao
Journal:  J Clin Exp Hepatol       Date:  2020-10-10

6.  Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database.

Authors:  Steven W Pipe; Rebecca Kruse-Jarres; Johnny N Mahlangu; Glenn F Pierce; Flora Peyvandi; Peter Kuebler; Christian De Ford; Fabián Sanabria; Richard H Ko; Tiffany Chang; Charles R M Hay
Journal:  J Thromb Haemost       Date:  2021-01       Impact factor: 5.824

7.  Cascade of Hepatitis C Virus Care Among Patients With Substance Use Disorders.

Authors:  Xinyi Jiang; Robert L Parker; Scott Martin Vouri; Weihsuan Lo-Ciganic; Vakaramoko Diaby; Linda Henry; Haesuk Park
Journal:  Am J Prev Med       Date:  2021-06-29       Impact factor: 6.604

8.  Covid-19: Time for a paradigm change.

Authors:  Franco M Buonaguro; Paolo A Ascierto; Gene D Morse; Luigi Buonaguro; Igor Puzanov; Maria Lina Tornesello; Christian Bréchot; Robert C Gallo
Journal:  Rev Med Virol       Date:  2020-07-03       Impact factor: 11.043

Review 9.  Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal.

Authors:  Alip Ghosh; Sara Romani; Shyam Kottilil; Bhawna Poonia
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

10.  Differentiation of exhausted CD8+ T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory.

Authors:  Pierre Tonnerre; David Wolski; Sonu Subudhi; Jihad Aljabban; Ruben C Hoogeveen; Marcos Damasio; Hannah K Drescher; Lea M Bartsch; Damien C Tully; Debattama R Sen; David J Bean; Joelle Brown; Almudena Torres-Cornejo; Maxwell Robidoux; Daniel Kvistad; Nadia Alatrakchi; Ang Cui; David Lieb; James A Cheney; Jenna Gustafson; Lia L Lewis-Ximenez; Lucile Massenet-Regad; Thomas Eisenhaure; Jasneet Aneja; W Nicholas Haining; Raymond T Chung; Nir Hacohen; Todd M Allen; Arthur Y Kim; Georg M Lauer
Journal:  Nat Immunol       Date:  2021-07-26       Impact factor: 25.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.